BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12921947)

  • 1. Molecular evidence for transferrin receptor 2 expression in all FAB subtypes of acute myeloid leukemia.
    Kollia P; Samara M; Stamatopoulos K; Belessi C; Stavroyianni N; Tsompanakou A; Athanasiadou A; Vamvakopoulos N; Laoutaris N; Anagnostopoulos A; Fassas A
    Leuk Res; 2003 Dec; 27(12):1101-3. PubMed ID: 12921947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated levels of transferrin receptor 2 mRNA, not transferrin receptor 1 mRNA, are associated with increased survival in acute myeloid leukaemia.
    Nakamaki T; Kawabata H; Saito B; Matsunawa M; Suzuki J; Adachi D; Tomoyasu S; Phillip Koeffler H
    Br J Haematol; 2004 Apr; 125(1):42-9. PubMed ID: 15015967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of transferrin receptor mRNA expression in acute myeloid leukaemia.
    Kollia P; Stavroyianni N; Stamatopoulos K; Zoi K; Viniou N; Mantzourani M; Noguchi CT; Paterakis G; Abazis D; Pangalos C; Loukopoulos D; Yataganas X
    Br J Haematol; 2001 Oct; 115(1):19-24. PubMed ID: 11722405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of transferrin receptor 1 and 2 in transferrin-bound iron uptake in human hepatoma cells.
    Herbison CE; Thorstensen K; Chua AC; Graham RM; Leedman P; Olynyk JK; Trinder D
    Am J Physiol Cell Physiol; 2009 Dec; 297(6):C1567-75. PubMed ID: 19828835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of expression of murine transferrin receptor 2.
    Kawabata H; Germain RS; Ikezoe T; Tong X; Green EM; Gombart AF; Koeffler HP
    Blood; 2001 Sep; 98(6):1949-54. PubMed ID: 11535534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cell proliferation on the uptake of transferrin-bound iron by human hepatoma cells.
    Lee AW; Oates PS; Trinder D
    Hepatology; 2003 Oct; 38(4):967-77. PubMed ID: 14512884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of transferrin receptor 2 in normal and neoplastic hematopoietic cells.
    Kawabata H; Nakamaki T; Ikonomi P; Smith RD; Germain RS; Koeffler HP
    Blood; 2001 Nov; 98(9):2714-9. PubMed ID: 11675342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of Hfe in transferrin-bound iron uptake by hepatocytes.
    Chua AC; Herbison CE; Drake SF; Graham RM; Olynyk JK; Trinder D
    Hepatology; 2008 May; 47(5):1737-44. PubMed ID: 18393371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of TfR2-Y250X and TfR1- rs3817672 Single Nucleotide Polymorphism on Pathophysiology of Iron Deficiency Anemia.
    Pandey S; Pandey SK; Shah V
    J Assoc Physicians India; 2019 Nov; 67(11):36-39. PubMed ID: 31793267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis.
    Fleming RE; Migas MC; Holden CC; Waheed A; Britton RS; Tomatsu S; Bacon BR; Sly WS
    Proc Natl Acad Sci U S A; 2000 Feb; 97(5):2214-9. PubMed ID: 10681454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted disruption of the hepatic transferrin receptor 2 gene in mice leads to iron overload.
    Wallace DF; Summerville L; Subramaniam VN
    Gastroenterology; 2007 Jan; 132(1):301-10. PubMed ID: 17241880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predominantly post-transcriptional regulation of activation molecules in chronic lymphocytic leukemia: the case of transferrin receptors.
    Chiotoglou I; Smilevska T; Samara M; Likousi S; Belessi C; Athanasiadou I; Stavroyianni N; Samara S; Laoutaris N; Vamvakopoulos N; Anagnostopoulos A; Fassas A; Stamatopoulos K; Kollia P
    Blood Cells Mol Dis; 2008; 41(2):203-9. PubMed ID: 18621559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transferrin receptor 2-alpha supports cell growth both in iron-chelated cultured cells and in vivo.
    Kawabata H; Germain RS; Vuong PT; Nakamaki T; Said JW; Koeffler HP
    J Biol Chem; 2000 Jun; 275(22):16618-25. PubMed ID: 10748106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transferrin receptor-1 and 2 expression in chronic lymphocytic leukemia.
    Smilevska T; Stamatopoulos K; Samara M; Belessi C; Tsompanakou A; Paterakis G; Stavroyianni N; Athanasiadou I; Chiotoglou I; Hadzidimitriou A; Athanasiadou A; Douka V; Saloum R; Laoutaris N; Anagnostopoulos A; Fassas A; Stathakis N; Kollia P
    Leuk Res; 2006 Feb; 30(2):183-9. PubMed ID: 16054692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analyses for binding of the transferrin family of proteins to the transferrin receptor 2.
    Kawabata H; Tong X; Kawanami T; Wano Y; Hirose Y; Sugai S; Koeffler HP
    Br J Haematol; 2004 Nov; 127(4):464-73. PubMed ID: 15521925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of transferrin receptor 2 in mononuclear cells from children with acute leukemia].
    Pan LL; Gao J; Chen TT; Ma ZG; Guo X; Zhu YP; Li Q; Yuan LX
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jan; 40(1):20-3, 76. PubMed ID: 19292036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transferrin receptor 2 is frequently expressed in human cancer cell lines.
    Calzolari A; Oliviero I; Deaglio S; Mariani G; Biffoni M; Sposi NM; Malavasi F; Peschle C; Testa U
    Blood Cells Mol Dis; 2007; 39(1):82-91. PubMed ID: 17428703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of transferrin receptor mRNA by transferrin-gallium in human myeloid HL60 and lymphoid CCRF-CEM leukaemic cells.
    Ul-Haq R; Chitambar CR
    Biochem J; 1993 Sep; 294 ( Pt 3)(Pt 3):873-7. PubMed ID: 8379943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype.
    Cascavilla N; Musto P; D'Arena G; Melillo L; Carella AM; Petrilli MP; Sanpaolo G; Carotenuto M
    Haematologica; 1998 May; 83(5):392-7. PubMed ID: 9658721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mRNA expression of leukemia-associated antigens in patients with acute myeloid leukemia for the development of specific immunotherapies.
    Greiner J; Ringhoffer M; Taniguchi M; Li L; Schmitt A; Shiku H; Döhner H; Schmitt M
    Int J Cancer; 2004 Feb; 108(5):704-11. PubMed ID: 14696097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.